Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".
FYF
Face Your Fears: an Assessor-blinded, RCT Evaluating the Effectiveness of Cognitive Behavioural Virtual Reality Therapy Versus Cognitive Behavioural Therapy in Patients with Schizophrenia Spectrum Disorders.
1 other identifier
interventional
254
1 country
1
Brief Summary
The study is a randomised, assessor-blinded parallel-groups superiority clinical trial fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients will be allocated to either Cognitive Behavioural Virtual Reality Therapy plus treatment as usual, versus traditional CBT for psychosis plus treatment as usual. All participants will be assessed at baseline and 3- and 9 months post baseline. A stratified block-randomisation with concealed randomisation sequence will be conducted. Independent assessors blinded to the treatment will evaluate outcome. Analysis of outcome will be carried out with the intention to treat principles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2021
CompletedFirst Submitted
Initial submission to the registry
April 19, 2021
CompletedFirst Posted
Study publicly available on registry
May 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2024
CompletedNovember 18, 2024
September 1, 2024
3 years
April 19, 2021
November 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
(GPTS) Green Paranoid Thought Scale Part B: Ideas of persecution.
The primary outcome is level of ideas of persecution measured with Green Paranoid Thought Scale at cessation of treatment at 3-months. The Green Paranoid Thought Scale has displayed good reliability and validity in patients with psychosis, displaying paranoid, persecutory delusions, and has also been used in patients at-risk for psychosis showing subthreshold psychotic symptoms. Minimum total score: 32. Maximum total score: 160. Part A (Ideas of social reference) minimum score: 16 and maximum score: 80. Part B (ideas of persecution) minimum score 16 and maximum score: 80. Part B score = or \> 45 are assumed to be threshold for development of persecutory delusion. Higher score means worse outcome.
3 months from inclusion
Secondary Outcomes (6)
SIAS (Social Interaction Anxiety Scale)
3 and 9 months from inclusion
SBQ (Safety Behaviour Questionnaire)
3 and 9 months from inclusion
PSP (Personal and Social Performance Scale)
3 and 9 months from inclusion
CANTAB ERT (Emotion Recognition Task)
3 and 9 months from inclusion
(GPTS) Green Paranoid Thought Scale Part A: Ideas of social reference
3 and 9 months from inclusion
- +1 more secondary outcomes
Other Outcomes (18)
CDSS (Calgary Depression Scale for Schizophrenia)
3 and 9 months from inclusion
BNSS (Brief Negative Symptom Scale)
3 and 9 months from inclusion
COGDIS (Cognitive disturbances scale)
3 and 9 months from inclusion
- +15 more other outcomes
Study Arms (2)
Cognitive Behavioural Virtual Reality Therapy (CBT-VR)
EXPERIMENTALThe CBT-VR consists of traditional CBT with the augmentation of virtual reality exposure. The virtual reality exposure comprises four virtual social environments (a bus, café, street, and supermarket). These are daily social situations that generally elicit paranoid thinking in patients with a schizophrenia spectrum disorder. While virtually engaging in these distressing situations, the therapist will facilitate a CBT dialogue aimed at generating alternative (i.e. non-threatening) thinking, diminishing safety behaviours (e.g. social isolation), and building up new coping strategies. This is expected to alleviate distress, anxiety, and improve daily social functioning. Preliminary findings reveal this virtual reality program to be well-tolerated and highly effective in reducing paranoia and anxiety in psychosis. Patients will be offered 10 individual sessions.
Traditional Cognitive Behavioural Therapy
ACTIVE COMPARATORThe treatment in the CBT group will follow the core principles of CBT used for psychotic disorders. The CBT treatment facilitates an individualised, problem-oriented approach, and uses key CBT techniques such as developing a problem and goal list, normalising psychotic-like experiences, evaluation of appraisals, and removing or diminishing safety behaviour. Patients will be offered 10 individual sessions.
Interventions
Cognitive Behavioural Therapy augmented with Virtual Reality.
Traditional Cognitive Behavioural Therapy for psychosis.
Eligibility Criteria
You may qualify if:
- Age 18 - years
- Ability to give informed consent
- A schizophrenia spectrum disorder (ICD-10 code: F20 -F29)
- Green Paranoid Thought Scale total score ≥ 40
You may not qualify if:
- Rejecting informed consent
- A diagnosis of organic brain disease
- IQ of 70 or lower (known mental retardation as assessed by medical record)
- A command of spoken Danish or English inadequate for engaging in therapy
- Inability to tolerate the assessment process
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhagen Research Center for Mental Health - CORE
Copenhagen, Hellerup, 2900, Denmark
Related Publications (3)
Jeppesen UN, Vernal DL, Due AS, Mariegaard LS, Pinkham AE, Austin SF, Vos M, Christensen MJ, Hansen NK, Smith LC, Hjorthoj C, Veling W, Nordentoft M, Glenthoj LB. Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial. Nat Med. 2025 Oct;31(10):3425-3439. doi: 10.1038/s41591-025-03880-8. Epub 2025 Aug 13.
PMID: 40804323DERIVEDJeppesen UN, Due AS, Mariegaard L, Pinkham A, Vos M, Veling W, Nordentoft M, Glenthoj LB. Update to the study protocol Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial. Trials. 2023 Jan 23;24(1):52. doi: 10.1186/s13063-023-07069-7.
PMID: 36691039DERIVEDJeppesen UN, Due AS, Mariegaard L, Pinkham A, Vos M, Veling W, Nordentoft M, Glenthoj LB. Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial. Trials. 2022 Aug 15;23(1):658. doi: 10.1186/s13063-022-06614-0.
PMID: 35971137DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Independent assessors blinded to the treatment will evaluate outcome. Investigator\'s conduct assessment and/or supervise assessments and are masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 19, 2021
First Posted
May 26, 2021
Study Start
April 9, 2021
Primary Completion
March 21, 2024
Study Completion
August 10, 2024
Last Updated
November 18, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share